These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 3259618)
1. Immunotherapy of head and neck cancer: an overview. Williamson A; Miller RH J La State Med Soc; 1988 Apr; 140(4):11-3. PubMed ID: 3259618 [No Abstract] [Full Text] [Related]
3. [Prospects for improving antibody therapy for carcinoma]. Liu XY Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1145-6. PubMed ID: 15387972 [No Abstract] [Full Text] [Related]
4. Immunotherapy in head and neck cancer: current practice and future possibilities. Agada FO; Alhamarneh O; Stafford ND; Greenman J J Laryngol Otol; 2009 Jan; 123(1):19-28. PubMed ID: 18761763 [TBL] [Abstract][Full Text] [Related]
5. A review of immunology and head and neck tumors. Church JM; Ryan RF Clin Plast Surg; 1976 Jul; 3(3):385-8. PubMed ID: 963948 [No Abstract] [Full Text] [Related]
6. [Criteria for evaluation of the efficacy of immunotherapy of bronchiectasis patients]. Gubergrits AIa; Monogarova NE; Sokhin AA Vrach Delo; 1986 May; (5):89-91. PubMed ID: 3727521 [No Abstract] [Full Text] [Related]
7. Potential of immuno-positron emission tomography for tumor imaging and immunotherapy planning. Zalutsky MR Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1958-60. PubMed ID: 16609003 [No Abstract] [Full Text] [Related]
8. Monoclonal antibodies (Mabs) in head and neck cancer. Poliquin JF; Filion LG J Otolaryngol; 1986 Oct; 15(5):289-92. PubMed ID: 3534285 [TBL] [Abstract][Full Text] [Related]
9. Carriers in cancer treatment: monoclonal antibodies. Sjögren HO Eur J Surg Suppl; 1991 May; (561):53-7. PubMed ID: 1720050 [No Abstract] [Full Text] [Related]
10. [Immunotherapy for head and neck squamous cell carcinoma]. Bron L; Romero P Rev Med Suisse; 2006 Oct; 2(81):2216-9. PubMed ID: 17076151 [TBL] [Abstract][Full Text] [Related]
11. Biologicals and biological response modifiers: fourth modality of cancer treatment. Oldham RK Cancer Treat Rep; 1984 Jan; 68(1):221-32. PubMed ID: 6198081 [TBL] [Abstract][Full Text] [Related]
12. Molecular therapy of head and neck cancer. Modjtahedi H Cancer Metastasis Rev; 2005 Jan; 24(1):129-46. PubMed ID: 15785877 [TBL] [Abstract][Full Text] [Related]
13. Perspectives of monoclonal antibodies for detection and treatment of head and neck tumours. Quak J; Gerretsen M; De Bree R; Brakenhof R; Van Dongen G; Snow G Anticancer Res; 1993; 13(6B):2533-9. PubMed ID: 8135493 [TBL] [Abstract][Full Text] [Related]
14. [Immunocompetence and immunotherapy in patients with cancer of the head and neck region]. Vinzenz K; Micksche M Z Stomatol; 1986 May; 83(3):203-18. PubMed ID: 3465128 [No Abstract] [Full Text] [Related]
15. [Interleukin 2 and local immunotherapy of head and neck cancer]. Wu H; Tu GY Zhonghua Er Bi Yan Hou Ke Za Zhi; 1991; 26(6):367-9. PubMed ID: 1811693 [No Abstract] [Full Text] [Related]
17. A murine model for the immunotherapy of head and neck squamous cell carcinoma. Hier MP; Black MJ; Shenouda G; Sadeghi N; Karp SE Laryngoscope; 1995 Oct; 105(10):1077-80. PubMed ID: 7564839 [TBL] [Abstract][Full Text] [Related]
18. Stage IV head and neck cancer: a follow-up. Ryan RF; Truesdale GL J La State Med Soc; 1982 Oct; 134(7):35-8. PubMed ID: 7175332 [No Abstract] [Full Text] [Related]
19. Current role of gene therapy in head and neck cancer. Ganly I; Soutar DS; Kaye SB Eur J Surg Oncol; 2000 Jun; 26(4):338-43. PubMed ID: 10873352 [TBL] [Abstract][Full Text] [Related]
20. Effects of monoclonal antibody immunotherapy on patients with gastrointestinal adenocarcinoma. Sears HF; Herlyn D; Steplewski Z; Koprowski H J Biol Response Mod; 1984; 3(2):138-50. PubMed ID: 6374043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]